BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC
· Real-Time Price · USD
5.66
-0.03 (-0.53%)
At close: Sep 03, 2025, 3:59 PM
-0.53% (1D)
| Bid | 4.12 |
| Market Cap | 10.17M |
| Revenue (ttm) | 9.55M |
| Net Income (ttm) | -2.93M |
| EPS (ttm) | -1.64 |
| PE Ratio (ttm) | -3.45 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.21 |
| Volume | 54,448 |
| Avg. Volume (20D) | 2,028,370 |
| Open | 5.79 |
| Previous Close | 5.69 |
| Day's Range | 5.65 - 5.79 |
| 52-Week Range | 2.01 - 15.60 |
| Beta | 1.90 |
About BGLC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BGLC
Website n/a
1 month ago
+60.99%
BioNexus Gene Lab shares are trading higher after ...
Unlock content with
Pro Subscription
3 months ago
+23.81%
Shares of companies within the broader industrial sector are trading higher, possibly amid overall market strength after President Trump delayed 50% EU tariffs to July.
